# Sedative Effects in Obstructive Sleep Apnea

> **NCT01733043** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01733043
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failure to secure funding
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733043, "Sedative Effects in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01733043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*